DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A strong ...

In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.

Medical device company DexCom (NASDAQ:DXCM) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 12.5% year on ...

Dexcom Inc. defeated investor allegations the glucose monitor maker exaggerated its ability to tap into the market of ...

The cause of type 1 diabetes remains unknown and is a central focus of Boston College Assistant Professor of Biology Emrah Altindis and others in his field hoping to find new ways to help 1.6 million ...

Lantz uses the Dexcom glucose monitor for her Type 1 diabetes and has joined the Dexcom U team, an NIL that helps athletes ...

Dexcom’s first-of-its-kind NIL program is accepting nominations for passionate and inspiring college athletes with diabetes for its 2025 roster now through May 23. Selected athletes will be ...

Type 1 diabetes is a chronic condition in which the pancreas produces little to no insulin. The role of Continuous Glucose Monitoring (CGM) system like Dexcom G7 in Nick's diabetes journey Nick ...

“Dexcom U has ignited a powerful movement over the past three years, providing athletes with diabetes a unique platform to excel and inspire,” said Leverne Marsh, executive vice president of ...

When I began this partnership, it was so cool to see thousands or even millions of other people in the world that also have Type 1 diabetes. When it narrowed down to Dexcom University, the coolest ...